Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302559 · ClinicalTrials.gov registry record · NA
Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03302559 is a NA study that has completed, run by Allergan. The registered enrollment target is 29 participants.
The verdict
NCT03302559, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study will assess the cosmetic changes of a cosmetic topical retinoid product in participants with moderate to severe photodamage utilizing non-invasive in vivo skin imaging instrumentation.
Interventions
- OTHER Sunscreen
- DEVICE Skin Imaging
- OTHER Facial cleanser
- OTHER Retinol Complex 0.5
- OTHER Moisturizing lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03302559
The ClinicalTrials.gov registry entry for NCT03302559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Sunscreen is the first listed.
NCT03302559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03302559 about?
NCT03302559 is a clinical study titled "Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage". This study will assess the cosmetic changes of a cosmetic topical retinoid product in participants with moderate to severe photodamage utilizing non-invasive in vivo skin imaging instrumentation.
What is the current status of trial NCT03302559?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-09-18. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03302559?
The interventions under investigation include: Sunscreen (OTHER), Skin Imaging (DEVICE), Facial cleanser (OTHER), Retinol Complex 0.5 (OTHER), Moisturizing lotion (OTHER).
Who is sponsoring clinical trial NCT03302559?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.